Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jul. 03, 2022	Jun. 27, 2021	Jun. 28, 2020
Operating activities:
Net income	$ 29,610	$ 118,652	$ 58,998
Reconciliation of net income to net cash provided by operating activities net of acquisitions:
Depreciation and amortization	49,078	42,510	32,513
Amortization of deferred financing costs	1,269	1,143	646
Deferred income taxes	1,579	5,530	(266)
Bad debt expense (recoveries)	(411)	964	4,143
Stock-based compensation	7,947	10,835	8,434
Other non-cash items	3,194	645	1,032
Changes in operating items:
Trade receivables	(2,452)	(5,236)	(6,947)
Inventories	(85,047)	(39,104)	(4,371)
Prepaid and other	6,731	(22,850)	(726)
Accounts payable and accrued expenses	(6,595)	57,397	44,359
Other assets and other liabilities	286	2,804	1,602
Net cash provided by operating activities	5,189	173,290	139,417
Investing activities:
Acquisitions, net of cash acquired	(21,280)	(250,942)	(20,500)
Capital expenditures, net of non-cash expenditures	(66,408)	(55,219)	(34,703)
Purchase of equity investments	(2,000)	(1,756)	(1,176)
Net cash used in investing activities	(89,688)	(307,917)	(56,379)
Financing activities:
Acquisition of treasury stock	(38,171)	(22,369)	(10,680)
Proceeds from exercise of employee stock options	846	2,253	285
Proceeds from bank borrowings	125,000	265,000	20,000
Repayment of notes payable and bank borrowings	(145,000)	(174,997)	(25,000)
Debt issuance costs	(284)	(2,193)	(60)
Net cash provided by (used in) financing activities	(57,609)	67,694	(15,455)
Net change in cash and cash equivalents	(142,108)	(66,933)	67,583
Cash and cash equivalents:
Beginning of year	173,573	240,506	172,923
End of year	$ 31,465	$ 173,573	$ 240,506